O-1602
O-1602 is a compound that is considered a G protein-coupled receptor (GPCR) agonist. It is often associated with the G protein-coupled receptor 55 (GPR55), which is a type of GPCR that is activated by lipids and is involved in various physiological processes. O-1602 is also known to interact with the cannabinoid receptor CB1 and CB2, although it has a much lower affinity for these receptors compared to other cannabinoids.
Structure and Properties[edit | edit source]
O-1602 is a synthetic compound that is structurally similar to the natural cannabinoid cannabidiol (CBD). It has a molecular formula of C26H26O2 and a molecular weight of 374.48 g/mol. The compound is typically a white crystalline solid at room temperature.
Pharmacology[edit | edit source]
O-1602 is primarily known for its activity at the GPR55 receptor. It acts as an agonist at this receptor, meaning it can activate the receptor and trigger a physiological response. This activity is thought to be responsible for many of the effects of O-1602, although the exact mechanisms are still not fully understood.
In addition to its activity at GPR55, O-1602 also interacts with the cannabinoid receptors CB1 and CB2. However, it has a much lower affinity for these receptors compared to other cannabinoids, meaning it is less likely to activate these receptors and produce typical cannabinoid effects.
Medical Uses[edit | edit source]
While O-1602 is not currently used in any approved medical treatments, it has been the subject of research for its potential therapeutic effects. Studies have suggested that O-1602 may have anti-inflammatory and analgesic effects, and it has been investigated for potential use in conditions such as chronic pain, inflammation, and neurodegenerative diseases.
See Also[edit | edit source]
O-1602 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD